Vanguard Group Inc Inovio Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.35 - $0.53 $108,069 - $163,648	-308,770 Reduced 1.54%	19,766,062 $10.1 Million
Q3 2023 Nov 14, 2023	BUY	$0.38 - $0.58 $2,640 - $4,030	6,949 Added 0.03%	20,074,832 $7.83 Million
Q2 2023 Aug 14, 2023	BUY	$0.39 - $0.94 $703,237 - $1.69 Million	1,803,172 Added 9.87%	20,067,883 $9.03 Million
Q1 2023 May 15, 2023	BUY	$0.79 - $1.91 $965,546 - $2.33 Million	1,222,211 Added 7.17%	18,264,711 $15 Million
Q4 2022 Feb 10, 2023	BUY	$1.41 - $2.5 $2.34 Million - $4.15 Million	1,660,191 Added 10.79%	17,042,500 $26.6 Million
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $3.34 Million - $5.61 Million	2,010,718 Added 15.04%	15,382,309 $26.5 Million
Q2 2022 Aug 12, 2022	BUY	$1.44 - $3.98 $3.06 Million - $8.45 Million	2,123,669 Added 18.88%	13,371,591 $23.1 Million
Q1 2022 May 13, 2022	BUY	$2.97 - $5.2 $619,568 - $1.08 Million	208,609 Added 1.89%	11,247,922 $40.4 Million
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $412,807 - $617,143	82,727 Added 0.76%	11,039,313 $55.1 Million
Q3 2021 Nov 12, 2021	BUY	$7.16 - $9.69 $59,184 - $80,097	8,266 Added 0.08%	10,956,586 $78.4 Million
Q2 2021 Aug 13, 2021	BUY	$6.23 - $10.03 $68.2 Million - $110 Million	10,948,320 New	10,948,320 $101 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $456M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.